rb 7040 has been researched along with rb 88716 in 2 studies
| Studies (rb 7040) | Trials (rb 7040) | Recent Studies (post-2010) (rb 7040) | Studies (rb 88716) | Trials (rb 88716) | Recent Studies (post-2010) (rb 88716) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 6 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, EJ; He, ZY; Hei, TK; Piao, CQ | 1 |
| Hall, EJ; Pirro, JP; Roizin-Towle, L | 1 |
2 other study(ies) available for rb 7040 and rb 88716
| Article | Year |
|---|---|
Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents | 1990 |
Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Topics: Antineoplastic Agents; Aziridines; Cell Line; Cell Survival; Humans; In Vitro Techniques; Lung Neoplasms; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents | 1990 |